Cargando…

Diabetes mellitus, cachexia and obesity in heart failure: rationale and design of the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF)

BACKGROUND: Chronic heart failure (CHF) is increasing in prevalence. Patients with CHF usually have co-morbid conditions, but these have been subjected to little research and consequently there is a paucity of guidance on how to manage them. Obesity and diabetes mellitus are common antecedents of CH...

Descripción completa

Detalles Bibliográficos
Autores principales: von Haehling, Stephan, Lainscak, Mitja, Doehner, Wolfram, Ponikowski, Piotr, Rosano, Giuseppe, Jordan, Jens, Rozentryt, Piotr, Rauchhaus, Mathias, Karpov, Rostislav, Tkachuk, Vsevolod, Parfyonova, Yelena, Zaritskey, Andrey Y., Shlyakhto, Eugeniy V., Cleland, John G., Anker, Stefan D.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3060647/
https://www.ncbi.nlm.nih.gov/pubmed/21475696
http://dx.doi.org/10.1007/s13539-010-0013-3
_version_ 1782200526804353024
author von Haehling, Stephan
Lainscak, Mitja
Doehner, Wolfram
Ponikowski, Piotr
Rosano, Giuseppe
Jordan, Jens
Rozentryt, Piotr
Rauchhaus, Mathias
Karpov, Rostislav
Tkachuk, Vsevolod
Parfyonova, Yelena
Zaritskey, Andrey Y.
Shlyakhto, Eugeniy V.
Cleland, John G.
Anker, Stefan D.
author_facet von Haehling, Stephan
Lainscak, Mitja
Doehner, Wolfram
Ponikowski, Piotr
Rosano, Giuseppe
Jordan, Jens
Rozentryt, Piotr
Rauchhaus, Mathias
Karpov, Rostislav
Tkachuk, Vsevolod
Parfyonova, Yelena
Zaritskey, Andrey Y.
Shlyakhto, Eugeniy V.
Cleland, John G.
Anker, Stefan D.
author_sort von Haehling, Stephan
collection PubMed
description BACKGROUND: Chronic heart failure (CHF) is increasing in prevalence. Patients with CHF usually have co-morbid conditions, but these have been subjected to little research and consequently there is a paucity of guidance on how to manage them. Obesity and diabetes mellitus are common antecedents of CHF and often complicate management and influence outcome. Cachexia is an ominous and often missed sign in patients with CHF. METHODS: This manuscript describes the rationale and the design of Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF), a prospective, multicentre, multinational, longitudinal, pathophysiological evaluation study, which is being conducted in 11 centres across six countries in the European Union and in Russia. We aim to recruit >1,600 patients with CHF due to various common aetiologies, irrespective of left ventricular ejection fraction, and with or without co-morbidities at study entry. In addition, >300 patients with type 2 diabetes mellitus without CHF and >150 healthy subjects will serve as control groups. Participants will be systematically investigated at annual intervals for up to 48 months. Additional investigations focusing on cellular and subcellular mechanisms, adipose and skeletal muscle tissue, and in endothelial progenitor cells will be performed in selected subgroups. CONCLUSIONS: SICA-HF will provide insights into common co-morbidities in CHF with a specific emphasis on diabetes mellitus and body mass. This will provide a more thorough pathophysiological understanding of the complexity of CHF that will help develop therapies tailored to manage specific co-morbidities.
format Text
id pubmed-3060647
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-30606472011-04-05 Diabetes mellitus, cachexia and obesity in heart failure: rationale and design of the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF) von Haehling, Stephan Lainscak, Mitja Doehner, Wolfram Ponikowski, Piotr Rosano, Giuseppe Jordan, Jens Rozentryt, Piotr Rauchhaus, Mathias Karpov, Rostislav Tkachuk, Vsevolod Parfyonova, Yelena Zaritskey, Andrey Y. Shlyakhto, Eugeniy V. Cleland, John G. Anker, Stefan D. J Cachexia Sarcopenia Muscle Original Article BACKGROUND: Chronic heart failure (CHF) is increasing in prevalence. Patients with CHF usually have co-morbid conditions, but these have been subjected to little research and consequently there is a paucity of guidance on how to manage them. Obesity and diabetes mellitus are common antecedents of CHF and often complicate management and influence outcome. Cachexia is an ominous and often missed sign in patients with CHF. METHODS: This manuscript describes the rationale and the design of Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF), a prospective, multicentre, multinational, longitudinal, pathophysiological evaluation study, which is being conducted in 11 centres across six countries in the European Union and in Russia. We aim to recruit >1,600 patients with CHF due to various common aetiologies, irrespective of left ventricular ejection fraction, and with or without co-morbidities at study entry. In addition, >300 patients with type 2 diabetes mellitus without CHF and >150 healthy subjects will serve as control groups. Participants will be systematically investigated at annual intervals for up to 48 months. Additional investigations focusing on cellular and subcellular mechanisms, adipose and skeletal muscle tissue, and in endothelial progenitor cells will be performed in selected subgroups. CONCLUSIONS: SICA-HF will provide insights into common co-morbidities in CHF with a specific emphasis on diabetes mellitus and body mass. This will provide a more thorough pathophysiological understanding of the complexity of CHF that will help develop therapies tailored to manage specific co-morbidities. Springer-Verlag 2010-12-17 2010-12 /pmc/articles/PMC3060647/ /pubmed/21475696 http://dx.doi.org/10.1007/s13539-010-0013-3 Text en © The Author(s) 2010 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Original Article
von Haehling, Stephan
Lainscak, Mitja
Doehner, Wolfram
Ponikowski, Piotr
Rosano, Giuseppe
Jordan, Jens
Rozentryt, Piotr
Rauchhaus, Mathias
Karpov, Rostislav
Tkachuk, Vsevolod
Parfyonova, Yelena
Zaritskey, Andrey Y.
Shlyakhto, Eugeniy V.
Cleland, John G.
Anker, Stefan D.
Diabetes mellitus, cachexia and obesity in heart failure: rationale and design of the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF)
title Diabetes mellitus, cachexia and obesity in heart failure: rationale and design of the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF)
title_full Diabetes mellitus, cachexia and obesity in heart failure: rationale and design of the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF)
title_fullStr Diabetes mellitus, cachexia and obesity in heart failure: rationale and design of the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF)
title_full_unstemmed Diabetes mellitus, cachexia and obesity in heart failure: rationale and design of the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF)
title_short Diabetes mellitus, cachexia and obesity in heart failure: rationale and design of the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF)
title_sort diabetes mellitus, cachexia and obesity in heart failure: rationale and design of the studies investigating co-morbidities aggravating heart failure (sica-hf)
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3060647/
https://www.ncbi.nlm.nih.gov/pubmed/21475696
http://dx.doi.org/10.1007/s13539-010-0013-3
work_keys_str_mv AT vonhaehlingstephan diabetesmellituscachexiaandobesityinheartfailurerationaleanddesignofthestudiesinvestigatingcomorbiditiesaggravatingheartfailuresicahf
AT lainscakmitja diabetesmellituscachexiaandobesityinheartfailurerationaleanddesignofthestudiesinvestigatingcomorbiditiesaggravatingheartfailuresicahf
AT doehnerwolfram diabetesmellituscachexiaandobesityinheartfailurerationaleanddesignofthestudiesinvestigatingcomorbiditiesaggravatingheartfailuresicahf
AT ponikowskipiotr diabetesmellituscachexiaandobesityinheartfailurerationaleanddesignofthestudiesinvestigatingcomorbiditiesaggravatingheartfailuresicahf
AT rosanogiuseppe diabetesmellituscachexiaandobesityinheartfailurerationaleanddesignofthestudiesinvestigatingcomorbiditiesaggravatingheartfailuresicahf
AT jordanjens diabetesmellituscachexiaandobesityinheartfailurerationaleanddesignofthestudiesinvestigatingcomorbiditiesaggravatingheartfailuresicahf
AT rozentrytpiotr diabetesmellituscachexiaandobesityinheartfailurerationaleanddesignofthestudiesinvestigatingcomorbiditiesaggravatingheartfailuresicahf
AT rauchhausmathias diabetesmellituscachexiaandobesityinheartfailurerationaleanddesignofthestudiesinvestigatingcomorbiditiesaggravatingheartfailuresicahf
AT karpovrostislav diabetesmellituscachexiaandobesityinheartfailurerationaleanddesignofthestudiesinvestigatingcomorbiditiesaggravatingheartfailuresicahf
AT tkachukvsevolod diabetesmellituscachexiaandobesityinheartfailurerationaleanddesignofthestudiesinvestigatingcomorbiditiesaggravatingheartfailuresicahf
AT parfyonovayelena diabetesmellituscachexiaandobesityinheartfailurerationaleanddesignofthestudiesinvestigatingcomorbiditiesaggravatingheartfailuresicahf
AT zaritskeyandreyy diabetesmellituscachexiaandobesityinheartfailurerationaleanddesignofthestudiesinvestigatingcomorbiditiesaggravatingheartfailuresicahf
AT shlyakhtoeugeniyv diabetesmellituscachexiaandobesityinheartfailurerationaleanddesignofthestudiesinvestigatingcomorbiditiesaggravatingheartfailuresicahf
AT clelandjohng diabetesmellituscachexiaandobesityinheartfailurerationaleanddesignofthestudiesinvestigatingcomorbiditiesaggravatingheartfailuresicahf
AT ankerstefand diabetesmellituscachexiaandobesityinheartfailurerationaleanddesignofthestudiesinvestigatingcomorbiditiesaggravatingheartfailuresicahf